EnlargeGetty | Joe Raedle reader comments 5 Share this story While facing intense outrage for repeatedly jacking up the price of their life-saving epinephrine auto-injectors, Mylan continually argued that patients were shielded from the soaring list price—thanks to insurance coverage, discounts, and rebates. But a new study looking into insurance claims...